Table 4. Comparison of Utilization of Maternal Health Services Between PBF and Control Samples at Baseline and Endline .
Outcome Variable |
Baseline | Endline | ||||||||||||
Total | PBF | Control | Difference | Total | PBF | Control | Difference | |||||||
n | Mean (%) | n | Mean (%) | n | Mean (%) | n | Mean (%) | n | Mean (%) | n | Mean (%) | |||
ANC 1st trimester | 6357 | 67.17 | 4909 | 67.39 | 1448 | 66.44 | 0.95 | 6168 | 73.98 | 4773 | 75.63 | 1395 | 68.32 | 7.31*** |
ANC4+a visits | 6564 | 44.20 | 5070 | 44.91 | 1494 | 41.77 | 3.14** | 6365 | 61.62 | 4928 | 62.50 | 1437 | 58.59 | 3.91*** |
TTV2+b | 6557 | 62.80 | 5065 | 62.65 | 1492 | 63.34 | -0.69*** | 6213 | 43.68 | 4810 | 43.10 | 1403 | 45.69 | -2.59* |
HIV testing in pregnancy | 6557 | 56.11 | 5065 | 57.14 | 1492 | 52.61 | 4.53 | 6215 | 54.88 | 4812 | 56.44 | 1403 | 49.54 | 6.90*** |
Iron supplementation | 6557 | 93.18 | 5065 | 92.99 | 1492 | 93.83 | -0.84 | 6209 | 98.20 | 4807 | 98.25 | 1402 | 98.00 | 0.25 |
Facility-based delivery | 6511 | 89.08 | 5024 | 88.42 | 1487 | 91.32 | -2.90*** | 6220 | 91.27 | 4807 | 91.72 | 1413 | 89.74 | 1.98** |
PNC1+c visit | 6488 | 53.21 | 5002 | 54.48 | 1486 | 48.92 | 5.56*** | 6194 | 76.40 | 4785 | 77.93 | 1409 | 71.19 | 6.74*** |
PNC3+d visits | 6488 | 5.50 | 5002 | 4.96 | 1486 | 7.34 | -2.38*** | 6194 | 13.63 | 4785 | 14.48 | 1409 | 10.72 | 3.76*** |
Modern planning family methods | 8643 | 11.25 | 6814 | 11.43 | 1829 | 10.55 | 0.88 | 8942 | 27.25 | 6806 | 27.80 | 2136 | 25.51 | 2.29 |
Abbreviations: TTV, tetanus toxoid vaccine; PNC, postnatal care; PBF, performance-based financing; ANC, Antenatal care.
aAt least 4 antenatal care; bAt least 2 tetanus doses during pregnancy; cAt least one postnatal care visit within 6 weeks; dAt least 3 postnatal care visits within 6 weeks
T test for differences between PBF and control samples; * P < .1, ** P < .05, *** P < .01.